Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Statistics

Total Valuation

KRX:002620 has a market cap or net worth of KRW 117.44 billion. The enterprise value is 351.58 billion.

Market Cap	117.44B
Enterprise Value	351.58B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:002620 has 15.35 million shares outstanding.

Current Share Class	15.35M
Shares Outstanding	15.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	76.13%
Owned by Institutions (%)	n/a
Float	2.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.16
PB Ratio	0.26
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.93, with an EV/FCF ratio of -19.03.

EV / Earnings	-9.99
EV / Sales	0.48
EV / EBITDA	11.93
EV / EBIT	23.44
EV / FCF	-19.03

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.38.

Current Ratio	1.14
Quick Ratio	0.76
Debt / Equity	0.38
Debt / EBITDA	5.77
Debt / FCF	-9.20
Interest Coverage	1.93

Financial Efficiency

Return on equity (ROE) is -6.92% and return on invested capital (ROIC) is 1.56%.

Return on Equity (ROE)	-6.92%
Return on Assets (ROA)	1.09%
Return on Invested Capital (ROIC)	1.56%
Return on Capital Employed (ROCE)	2.87%
Revenue Per Employee	19.89B
Profits Per Employee	-950.98M
Employee Count	37
Asset Turnover	0.85
Inventory Turnover	4.15

Taxes

Income Tax	-192.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.81% in the last 52 weeks. The beta is 0.58, so KRX:002620's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-7.81%
50-Day Moving Average	8,569.80
200-Day Moving Average	8,216.75
Relative Strength Index (RSI)	26.10
Average Volume (20 Days)	9,851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:002620 had revenue of KRW 735.79 billion and -35.19 billion in losses. Loss per share was -2,292.49.

Revenue	735.79B
Gross Profit	223.81B
Operating Income	15.00B
Pretax Income	-30.73B
Net Income	-35.19B
EBITDA	29.48B
EBIT	15.00B
Loss Per Share	-2,292.49

Balance Sheet

The company has 71.18 billion in cash and 169.98 billion in debt, giving a net cash position of -98.80 billion or -6,436.09 per share.

Cash & Cash Equivalents	71.18B
Total Debt	169.98B
Net Cash	-98.80B
Net Cash Per Share	-6,436.09
Equity (Book Value)	445.68B
Book Value Per Share	20,215.79
Working Capital	44.07B

Cash Flow

In the last 12 months, operating cash flow was -12.30 billion and capital expenditures -6.18 billion, giving a free cash flow of -18.48 billion.

Operating Cash Flow	-12.30B
Capital Expenditures	-6.18B
Free Cash Flow	-18.48B
FCF Per Share	-1,203.78

Margins

Gross margin is 30.42%, with operating and profit margins of 2.04% and -4.78%.

Gross Margin	30.42%
Operating Margin	2.04%
Pretax Margin	-4.18%
Profit Margin	-4.78%
EBITDA Margin	4.01%
EBIT Margin	2.04%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.63%.

Dividend Per Share	50.00
Dividend Yield	0.63%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.63%
Earnings Yield	-29.96%
FCF Yield	-15.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 17, 2006. It was a forward split with a ratio of 10.

Last Split Date	Apr 17, 2006
Split Type	Forward
Split Ratio	10

Scores

KRX:002620 has an Altman Z-Score of 1.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.23
Piotroski F-Score	4